ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Trends in disease burden of ADHD in China from 1990 to 2019 based on GBD analysis.
Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- National and subnational burden of mental disorders in China, 1990-2023: a systematic analysis of the Global Burden of Disease Study 2023.The Lancet regional health. Western Pacific · 2026Article
- Determinants of ADHD Health Literacy and Public Awareness of Child-Friendly City Policies in Wenzhou: A Cross-Sectional Survey.Neuropsychiatric disease and treatment · 2026Article
- [Changes and forecast of the disease burden of senile dementias among Chinese residents from 1992 to 2021].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025Article
- [Analysis and prediction of the disease burden of attention-deficit/hyperactivity disorder in Chinese children and adolescents from 1990 to 2021].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025Article
- [Trends in the incidence and mortality of rheumatoid arthritis in China from 1990 to 2021: An ageZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesAttention deficit hyperactivity disorder (ADHD) has a significant impact on individual health and society. This study aims to analyze the disease burden of ADHD in China from 1990 to 2019 and make predictions to provide a basis for the formulation of corresponding prevention and control strategies by the government.
methodsUsing data from Global Burden of Diseases (GBD) 2019 database, we described the changes in incidence, prevalence, and disability-adjusted life years (DALY) in China from 1990 to 2019. An autoregressive integrated moving average model (ARIMA) was used to predict the disease burden from 2020 to 2029.
resultsFrom 1990 to 2019, the incidence, prevalence and DALY rates of ADHD all showed an upward trend, with standardized rates for males significantly higher than those for females. The age group of 5 to 9 years showed a higher incidence. Both prevalence and DALY rates peaked at ages 10 to 14, gradually declining with increasing age, although ADHD continues to impose a certain disease burden on adults. Prediction results indicate a slow decline in the standardized incidence rate of ADHD in China from 2020 to 2029, with standardized prevalence and standardized DALY rates showing a gradual increase from 2020 to 2025, followed by a decrease, potentially reaching 112.28/100 000, 2 070.03/100 000, and 25.41/100 000 by 2 029, respectively.
conclusionsADHD is a condition that spans the entire lifespan, yet current recognition, diagnosis, and treatment of adult ADHD remain insufficient. It is recommended to focus on the early diagnosis and treatment of adult ADHD based on existing disease monitoring to mitigate the impact of the disease on patients and society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.